C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
11/2011
11/24/2011	US20110288054 Compounds for the treatment of inflammatory disorders
11/24/2011	US20110287937 Ring-fused 2-pyridone derivatives and herbicides
11/24/2011	US20110287549 Time temperature indicator based on thioalkyl and thioaryl substituted spiroaromatics
11/24/2011	CA2800161A1 Modulators of 5-ht receptors and methods of use thereof
11/23/2011	EP2387577A2 Non-peptidyl, potent, and selective mu opioid receptor antagonists
11/23/2011	EP2387576A2 New materials with aza-dibenzothiophene or aza-dibenzofuran core for pholed
11/23/2011	EP1907371B1 Process for preparing 2-methoxycarbonylmethyl-6,6-dimethyl-2- tetrahydropyran carboxylic acid
11/23/2011	EP1391451B1 2-iminopyrrolidine derivates
11/23/2011	CN102257029A Pi-electron conjugated compound, manufacturing method therefor, and pi-electron conjugated polymer obtained using same
11/23/2011	CN102256983A Spiro-oxindole compounds and their use as therapeutic agents
11/23/2011	CN102255049A Organic thin-film solar cell and preparation method thereof
11/23/2011	CN102250105A Camptothecin derivatives, synthesis method thereof and use thereof
11/23/2011	CN102250104A Camptothecin derivative, and its synthetic method and application
11/23/2011	CN102250103A Synthesis method of SN38 or intermediate thereof
11/23/2011	CN102250071A Pyrazole compounds useful as protein kinase inhibitors
11/23/2011	CN101628919B Camptothecin, self-emulsifying medicine precursor of derivative thereof and application thereof
11/23/2011	CN101093222B Fluorescent probe in use for detecting glutathion inside cell, synthesis method and application
11/22/2011	US8063218 Imidazopyridine inhibitors of IAP
11/22/2011	US8063096 Spirocyclic 3-phenyl-3substituted-4-ketolactams and-lactones
11/22/2011	US8063093 Potassium channel blockers and uses thereof
11/22/2011	US8063063 Immunopotentiating compounds
11/22/2011	US8063060 R(−)-11-hydroxyaporphine derivatives and uses thereof
11/22/2011	CA2484395C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof
11/17/2011	WO2011143365A1 Nitrogen heterocyclic compounds useful as pde10 inhibitors
11/17/2011	WO2011143150A1 Substituted phenyl cycloalkyl pyrrolidine (piperidine) spirolactams and amides, preparation and therapeutic use thereof
11/17/2011	WO2011143148A1 Substituted n-heteroaryl spirolactam bipyrrolidines, preparation and therapeutic use thereof
11/17/2011	WO2011142620A2 (+)-3-hydroxymorphinan-based polycycle derivatives as neuroprotectants
11/17/2011	WO2011141474A1 Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
11/17/2011	US20110281903 Bicyclic heterocyclic spiro compounds
11/17/2011	US20110281856 Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said conjugates
11/17/2011	US20110280804 Highly selective sigma receptor radioligands
11/17/2011	CA2798490A1 Nitrogen heterocyclic compounds useful as pde10 inhibitors
11/16/2011	EP2385972A1 Preparation of a photochromic ink
11/16/2011	EP2385947A1 Time temperature indicator comprising indolenin based spiropyrans
11/16/2011	EP2385832A1 Phosphoinositide 3-kinase inhibitors with a zinc binding moiety
11/16/2011	CN102241891A Pyrazolopyridine coumarin dye derivative, and synthesis method and application thereof
11/16/2011	CN102241683A Extraction method for seneciphyllin
11/16/2011	CN102241682A Preparation method for fissistigine A
11/16/2011	CN102241678A Antitumor effect and application of alicyclic structure-containing compound
11/16/2011	CN102241621A 5,5-disubstituted-2-iminopyrrolidine derivatives, preparation method thereof, and medical applications thereof
11/15/2011	US8058452 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
11/15/2011	US8058290 E.g., 1-[4-(3-amino-1H-pyrazolo[3,4-b]pyridin-6-yl)phenyl]-3-(2-fluoro-5-trifluoromethylphenyl)urea; and N-(6-{4-[3-(2-fluoro-5-trifluoromethylphenyl)ureido]-phenyl}-1H-pyrazolo[3,4-b]pyridin-3-yl))thiophene-3-carboxamide; kinase inhibitors, anticancer agents
11/15/2011	US8058288 Amido compounds and their use as pharmaceuticals
11/15/2011	US8058287 Chemokine receptor antagonists and methods of use therefor
11/15/2011	US8058210 Arylphenyl-substituted cyclic keto-enols
11/15/2011	CA2598690C Small molecule inhibitors of mdm2 and uses thereof
11/15/2011	CA2532193C 7-polyaminoalkyl(oxy)iminomethylcamptothecins bearing protective groups
11/10/2011	WO2011140425A1 Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
11/10/2011	WO2011139275A1 Method of detecting nerve agents using novel assay agents
11/10/2011	WO2011137925A1 New pro-drugs of amaryllidaceae isocarbostyril products and their use against brain tumors
11/10/2011	WO2010135751A3 Fluorescent cellular markers
11/10/2011	US20110275609 Bicyclic pyrazolo-heterocycles
11/10/2011	US20110275161 Method of detecting nerve agents using novel assay agents
11/10/2011	US20110272644 Fluidic devices comprising photocontrollable units
11/10/2011	DE102010019306A1 Organische Elektrolumineszenzvorrichtungen Organic electroluminescent
11/10/2011	CA2812526A1 Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
11/09/2011	EP2385072A1 Novel compound, polymerizable composition, color filter and process for produciton thereof, solid-state imaging element, and lithographic printing original plate
11/09/2011	EP2385039A1 2-Iminoisoindolinone derivatives as thrombin receptor antagonists
11/09/2011	EP2041139B1 Pharmaceutical compounds
11/09/2011	EP1786812B1 Pyridine methylene azolidinones and their use as phosphoinositide inhibitors
11/09/2011	CN102239170A Substituted tetrahydropyran spiro pyrrolidinone and piperidinone, preparation and therapeutic use thereof
11/09/2011	CN102234286A Condensed heteroaryl derivatives
11/09/2011	CN102234282A Preparation method of allocryptopine
11/09/2011	CN101528718B Modulators of glucocorticoid receptor, AP-1, and/or NF-kB activity and use thereof
11/09/2011	CN101443332B Anti-viral pyrimidine nucleoside derivatives
11/09/2011	CN101175565B Manufacture of lactones
11/08/2011	US8053576 Treating conditions associated with the nociceptin/ORL1 receptor system, e.g. pain, drug withdrawal, anxiety, muscle relaxants, anxiolytic agents; e.g. 1,1-[3-dimethylamino-3-(pyridin-2-yl)pentamethylene]-3,4-dihydro-1H-2,9-diazafluorene
11/08/2011	US8053450 P2Y1 Purinoreceptor; thromboembolic disorders; compounds are 2-((hetero)arylamino) benzimidazoles, benzoxazoles or benzothiazoles such as [2-(2-tert-butyl-phenoxy)-pyridin-3-yl]-(6-methyl-1H-benzoimidazol-2-yl)-amine
11/08/2011	CA2643300C Trans-fused chromenoisoquinolines, synthesis and methods for use
11/03/2011	WO2011137072A1 Bicarbazole containing compounds for oleds
11/03/2011	WO2011136264A1 [5,6] heterocyclic compound
11/03/2011	WO2011136161A1 Prophylactic or therapeutic medication for inner ear disorders
11/03/2011	WO2010052569A8 Triazine, pyrimidine and pyridine analogs and their use as therapeutic agents and diagnostic probes
11/03/2011	US20110269969 Total synthesis of salinosporamide a and analogs thereof
11/03/2011	US20110269960 Triazole derivative
11/03/2011	US20110269789 Compositions and Methods for Achieving Sustained Therapeutic Drug Concentrations in a Subject
11/03/2011	US20110269788 Spiro-oxindole-derivatives as sodium channel blockers
11/03/2011	US20110269773 Dihydrofuro pyrimidines as akt protein kinase inhibitors
11/03/2011	US20110269242 Time temperature indicator comprising indolenin based spiropyrans
11/03/2011	US20110267714 Novel compound, polymerizable composition, color filter, and method of producing the same, solid-state imaging device, and planographic printing plate precursor
11/03/2011	CA2791360A1 A pharmaceutical for preventing or treating an inner ear disorder
11/03/2011	CA2791020A1 [5,6] heterocyclic compound
11/02/2011	EP2382215A1 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof
11/02/2011	EP2381944A1 Anti-viral compounds, treatment, and assay
11/02/2011	EP2278973B1 Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitors
11/02/2011	EP2069354B1 Aza-benzofuranyl compounds and methods of use
11/02/2011	EP1856124B1 New synthesis of a camptothecin subunit
11/02/2011	EP1730110B9 Sulfur compounds as inhibitors of hepatitis c virus ns3 serine protease
11/02/2011	CN102232078A 5-amino-2-(1-hydroxy-ethyl)-tetrahydropyran derivatives
11/02/2011	CN102232077A Organic compounds
11/02/2011	CN102229615A Method for synthesizing 9-nitrocamptothecin
11/02/2011	CN102229614A Method for synthesizing 9-aminocamptothecin
11/02/2011	CN102229613A New process for synthesis of asenapine
11/02/2011	CN101659667B Method for purifying irinotecan hydrochloride
11/02/2011	CN101544651B Method for synthesizing polysubstitution pyridinone compounds
11/01/2011	US8048878 Two cyclic cinnamide compound
11/01/2011	CA2657550C Benzimidazole derivatives as selective acid pump inhibitors
11/01/2011	CA2649521C Novel piperazine compound, and use thereof as hcv polymerase inhibitor
11/01/2011	CA2481261C Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds
11/01/2011	CA2448094C Method for preparation of 10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide and 10,11-dihydro-10-0x0-5h-dibenz/b,f/azepine-5-carboxamide

1 ... 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 ... 298